SCOPUS 정보 검색 플랫폼

Journal of Clinical Psychopharmacology

Volumn 31, Issue 3, 2011, Pages 382-384

Incidence of extrapyramidal syndromes and tardive dyskinesia

(2) Baldessarini, Ross J a Gardner, David M b

a HARVARD MEDICAL SCHOOL (United States)

b DALHOUSIE UNIVERSITY (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AKATHISIA; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FOLLOW UP; HUMAN; LETTER; PARKINSONISM; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; EPIDEMIOLOGIC RESEARCH DESIGN; EUROPE; HUMANS; INCIDENCE; MOVEMENT DISORDERS; PROSPECTIVE STUDIES;

EID: 79955611435 PISSN: 02710749 EISSN: 1533712X Source Type: Journal
DOI: 10.1097/JCP.0b013e3182192a58 Document Type: Letter

Times cited : (4)

References (8)

1
- 77957267779
- Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia
- Novick D, Haro JM, Bertsch J, et al. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia. J Clin Psychopharmacol. 2010;30:531-540.
- (2010) J Clin Psychopharmacol , vol.30 , pp. 531-540
- Novick, D.¹ Haro, J.M.² Bertsch, J.³

2
- 33646944093
- Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?
- DOI 10.1002/mds.20823
- Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord. 2006;21:589-598. (Pubitemid 43792739)
- (2006) Movement Disorders , vol.21 , Issue.5 , pp. 589-598
- Tarsy, D.¹ Baldessarini, R.J.²

3
- 78149418747
- Second-generation antipsychotic drugs and extrapyramidal side effects: Systematic review and meta-analysis of head-to-head comparisons
- [Epub ahead of print]
- Rummel-Kluge C, Komossa K, Schwarz S, et al. Second-generation antipsychotic drugs and extrapyramidal side effects: systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull. 2010. [Epub ahead of print].
- (2010) Schizophr Bull
- Rummel-Kluge, C.¹ Komossa, K.² Schwarz, S.³

4
- 21244487457
- Modern antipsychotic drugs: A critical overview
- DOI 10.1503/cmaj.1041064
- Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic agents: a critical overview. CMAJ. 2005;172:1703-1711. (Pubitemid 40896865)
- (2005) Canadian Medical Association Journal , vol.172 , Issue.13 , pp. 1703-1711
- Gardner, D.M.¹ Baldessarini, R.J.² Waraich, P.³

5
- 77952974468
- International consensus study of antipsychotic dosing
- Gardner DM, Murphy AL, O'Donnell H, et al. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686-693.
- (2010) Am J Psychiatry , vol.167 , pp. 686-693
- Gardner, D.M.¹ Murphy, A.L.² O'Donnell, H.³

6
- 30144440088
- Drugs for psychosis and mania
- Chapter 18 Brunton LL, Lazo JS, Parker KL, eds 11th ed. New York: McGraw-Hill Press
- Baldessarini RJ, Tarazi FI. Drugs for psychosis and mania. Chapter 18. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill Press; 2005:461-500.
- (2005) Goodman and Gilman's Goodman and Gilman's the Pharmacological Basis of Therapeutics , pp. 461-500
- Baldessarini, R.J.¹ Tarazi, F.I.²

7
- 0025805153
- Channeling bias in the interpretation of drug effects
- Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med. 1991;10:577-581.
- (1991) Stat Med , vol.10 , pp. 577-581
- Petri, H.¹ Urquhart, J.²

8
- 77955747787
- Minimizing bias in randomized trials: The importance of blinding
- Psaty BM, Prentice RL. Minimizing bias in randomized trials: the importance of blinding. JAMA. 2010;304:793-794.
- (2010) JAMA , vol.304 , pp. 793-794
- Psaty, B.M.¹ Prentice, R.L.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.